Cognition Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing small molecule therapeutics for age-related degenerative disorders of the central nervous system and retina. The company's lead candidate, zervimesine, is being investigated for Alzheimer’s disease, dementia with Lewy bodies, and dry age-related macular degeneration.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.